Type 1 Diabetes

Recently diagnosed with Type 1 Diabetes? Take action.
Learn more: teplizumab
Learn more: ClinicalTrials.gov

Learn more: Protégé Encore site

West Nile Virus

West Nile Virus Phase 2 clinical study.
Learn more: ClinicalTrials.gov Learn more: MGAWN1

Careers

MacroGenics has several positions for full-time employment currently open .

Learn more

Partnering

MacroGenics is pursuing alliances to participate in development of its proprietary product candidates and technology platforms.

Learn more

Home»News & Media»Press Releases

Press Releases

July 15, 2010
MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding further Advances DART Platform and Infectious Disease Portfolio

January 07, 2010
MacroGenics Appoints New Senior Vice President of Clinical Development

July 13, 2009
MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus

June 23, 2009
Paulo F. Costa Joins MacroGenics Board of Directors

June 16, 2009
MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTÉGÉ, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes

March 26, 2009
MacroGenics Appoints New Vice President of Business Development

September 25, 2008
MacroGenics Raises $25M in Series D-2 Financing

July 17, 2008
MacroGenics Acquires Raven Biotechnologies

May 06, 2008
Macrogenics Appoints New Chief Commercial Officer and Chief Financial Officer

October 18, 2007
Lilly and MacroGenics Announce Licensing and Collaboration Agreement

Press Release Archive: 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | View All